Last reviewed · How we verify

NCT02201732: HY-PER

Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions

Completed NA Last updated 5 September 2025
What this trial tests

NA trial testing Hysteroscopy in Incomplete Miscarriage in 577 participants. Completed in 3 July 2020.

Timeline
5 November 2014
Primary endpoint
15 November 2019
3 July 2020

Quick facts

Lead sponsorAssistance Publique - Hôpitaux de Paris
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment577
Start date5 November 2014
Primary completion15 November 2019
Estimated completion3 July 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 18 to 44, female only, with Incomplete Miscarriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study of is to compare subsequent fertility rates between hysteroscopy and aspirative curettage in the surgical treatment of incomplete spontaneous abortion

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Operative Hysteroscopy vs Vacuum Aspiration for Incomplete Spontaneous Abortion: A Randomized Clinical Trial.
    Huchon C, Drioueche H, Koskas M, Agostini A, et al · · 2023 · cited 21× · PMID 37039805 · DOI 10.1001/jama.2023.3415
  2. Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial.
    Huchon C, Koskas M, Agostini A, Akladios C, et al · · 2015 · cited 6× · PMID 26282937 · DOI 10.1186/s13063-015-0900-1

Verify or expand the search:

Other trials of Hysteroscopy

Trials testing the same drug.

Other recruiting trials for Incomplete Miscarriage

Currently open trials in the same condition.

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02201732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing